GB1184538A - alpha-Alkyl-5-Hydroxytryptophan Esters - Google Patents

alpha-Alkyl-5-Hydroxytryptophan Esters

Info

Publication number
GB1184538A
GB1184538A GB653769A GB653769A GB1184538A GB 1184538 A GB1184538 A GB 1184538A GB 653769 A GB653769 A GB 653769A GB 653769 A GB653769 A GB 653769A GB 1184538 A GB1184538 A GB 1184538A
Authority
GB
United Kingdom
Prior art keywords
alkyl
inclusive
carbon atoms
sedative
feb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB653769A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1184538A publication Critical patent/GB1184538A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
GB653769A 1968-02-16 1969-02-06 alpha-Alkyl-5-Hydroxytryptophan Esters Expired GB1184538A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70592268A 1968-02-16 1968-02-16

Publications (1)

Publication Number Publication Date
GB1184538A true GB1184538A (en) 1970-03-18

Family

ID=24835493

Family Applications (1)

Application Number Title Priority Date Filing Date
GB653769A Expired GB1184538A (en) 1968-02-16 1969-02-06 alpha-Alkyl-5-Hydroxytryptophan Esters

Country Status (6)

Country Link
BE (1) BE728421A (un)
DE (1) DE1906322A1 (un)
ES (1) ES363559A1 (un)
FR (1) FR2002067A1 (un)
GB (1) GB1184538A (un)
NL (1) NL6902421A (un)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256641A (en) 1976-06-22 1981-03-17 Hoffmann-La Roche Inc. Novel syntheses of tryptophans
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
JP2011513368A (ja) * 2008-03-05 2011-04-28 ４エスツェー アクチェンゲゼルシャフト 鏡像異性的に純粋なインドロピリジンの調製方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073795A (en) * 1976-06-22 1978-02-14 Hoffmann-La Roche Inc. Synthesis of tryptophans
JPH06509087A (ja) * 1991-07-05 1994-10-13 メルク　シヤープ　エンド　ドーム　リミテツド 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256641A (en) 1976-06-22 1981-03-17 Hoffmann-La Roche Inc. Novel syntheses of tryptophans
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
JP2011513368A (ja) * 2008-03-05 2011-04-28 ４エスツェー アクチェンゲゼルシャフト 鏡像異性的に純粋なインドロピリジンの調製方法

Also Published As

Publication number Publication date
DE1906322A1 (de) 1969-09-25
ES363559A1 (es) 1971-01-01
BE728421A (un) 1969-08-14
FR2002067A1 (fr) 1969-10-03
NL6902421A (un) 1969-08-19

Similar Documents

Publication Publication Date Title
GB1222708A (en) Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
IL70964A (en) (2-oxo-1,2,3,5-tetrahydro-imidazo(2,1-b)quinazolinyl)-oxyalkylamides,their preparation and pharmaceutical compositions containing them and some intermediates therefor
GB1301134A (en) SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1172034A (en) Substituted 3-Ureidopyrrolidines
GB1461209A (en) Thienyl and thietyl compounds
GB1260848A (en) Propanolamine derivatives
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
GB1456175A (en) Therapeutic urea derivatives
GB1184538A (en) alpha-Alkyl-5-Hydroxytryptophan Esters
IE39577L (en) Pharmaceutical compositions
GB1413455A (en) Alpha-cycloalkylbenzyl lactamimides
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1156781A (en) New Heterocyclic Compounds
GB1492622A (en) Aralkyl esters of amino alkanoic acids
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
GB1470493A (en) Anti-hypertensive 4-1-2-naphthyl-methyl-1,2,5,6-tetrahydro pyrid-4-yl-chroman-5-ol esters
GB1159223A (en) Novel N-Substituted Azabicyclooctanes and -Nonanes and the preparation thereof
GB1273399A (en) Novel formamido-cycloalkane derivatives
GB1471901A (en) Styrylamidines
GB1269774A (en) Benzodioxole compounds
GB1129749A (en) Derivatives of azabicyclo-octane and nonane and the manufacture thereof
GB1050150A (un)
GB1011039A (en) Improvements in or relating to propynylamides
GB1329510A (en) Aralkanoylcyclopentadiones

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed